Clinical Trial Update: ABC-04 a Study of Cisplatin, Gemcitabine and Selumetinib in Patients With Advanced Biliary Tract Cancer [Phase 1]

View source ↗

Summary

Phase 1 study ABC-04 evaluated cisplatin, gemcitabine, and selumetinib in patients with advanced biliary tract cancers. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Cholangiocarcinoma
• Gallbladder Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)
• Selumetinib (selumetinib)

Snippet

Sponsor: University College, London | Conditions: Biliary Tract Neoplasms, Cholangiocarcinoma | Phase 1 | Status: COMPLETED